Gastro retentive drug delivery systems: a review
Keywords:
Bioavailability; Gastrorentive drug delivery systems (GRDDS); In vitro drug release; Hydrocolloids plasma concentration; Polymers; Therapeutic effect.Abstract
In recent years, many efforts have been made in order to improve drug bioavailability after oral administration.
Gastroretentive drug-delivery systems (GRDDS) provide a mean for controlled release of compounds that are
absorbed by active transport in the upper intestine. They have the potential to prolong the gastric retenti on time
and provide controlled/sustained release of a drug at the absorption site, thereby improving the bioavailability.
Several approaches are used to increase the gastric residence time, namely bioadhesive or mucoadhesive
systems, expandable systems, high-density systems, floating systems, superporous hydrogels and magnetic
systems. The present review highlights some of the drugs that can benefit from gastroretentive strategies, such
as the factors that influence gastric retention time and the mechanism of action of gastroretentive systems, as
well as their classification into single and multiple unit systems. In the future, it is expected that they will
become of significance in drug therapies.
Published
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.